V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002081 | 240002081 | null | null | null | null | 2017-04-21 | Hydroxycarbamide | null | null | CHOP R | 101260272 |
| 240002089 | 240002089 | 1.62 | 67 | Curative (C) | 2018-11-25 | 2018-11-25 | null | 1 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100429034 |
| 240002092 | 240002092 | null | null | null | null | 2016-09-11 | BENDAMUSTINE + RITUXIMAB | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101297178 |
| 240002095 | 240002095 | 1.83 | 70.2 | Curative (C) | null | 2019-07-17 | Cladribine (subcut) 5 days | 02 | Y | AZACITIDINE | 100422299 |
| 240002097 | 240002097 | 1.62 | 67.3 | Curative (C) | null | 2017-09-22 | null | 02 | N | CHOP R | 101107993 |
| 240002110 | 240002110 | null | null | null | null | 2016-11-11 | FCR | null | null | TRIPLE INTRATHECAL | 100107521 |
| 240002112 | 240002112 | 1.7 | 68.4 | Curative (C) | null | 2017-01-19 | Hydroxycarbamide | 02 | N | AML16 TRIAL | 100761216 |
| 240002120 | 240002120 | 1.89 | 114 | Curative (C) | 2017-08-09 | 2017-08-09 | DA 3 + 10 | 02 | N | AML18 TRIAL | 100442270 |
| 240002126 | 240002126 | 1.75 | 84.4 | Curative (C) | null | 2018-02-28 | null | 2 | N | AML19 TRIAL | 101434986 |
| 240002128 | 240002128 | 1.63 | 54.9 | Curative (C) | null | 2018-02-07 | null | N | N | CLADRIBINE | 100688055 |
| 240002139 | 240002139 | 1.8 | 0 | Curative (C) | null | 2019-02-16 | null | N | N | METHOTREXATE | 101165821 |
| 240002144 | 240002144 | 1.73 | 146.4 | Curative (C) | null | 2018-05-04 | DA | 02 | N | RITUXIMAB | 100133154 |
| 240002145 | 240002145 | null | null | null | null | 2018-12-10 | FCR | null | null | ALL UKALL2011 IND B | 100157753 |
| 240002149 | 240002149 | 0 | 72 | Curative (C) | 2018-03-07 | 2018-03-08 | AML 18 TRIAL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100262396 |
| 240002151 | 240002151 | 0 | null | Curative (C) | 2016-02-23 | 2016-02-23 | null | N | N | IMATINIB | 100461569 |
| 240002153 | 240002153 | 1.53 | 82.6 | Palliative (P) | null | 2018-08-16 | Bendamustine+Rituximab (1st Course) | null | N | CHOP R | 100732469 |
| 240002155 | 240002155 | 0 | 66.3 | 03 | 2019-09-20 | 2019-09-22 | null | 02 | Y | GEMTUZUMAB OZOGAMICIN | 101547749 |
| 240002159 | 240002159 | 1.71 | 73.2 | Curative (C) | 2016-09-10 | 2016-09-11 | null | 02 | N | CHOP R | 101722751 |
| 240002162 | 240002162 | 1.79 | 121 | Adjuvant (A) | 2019-07-30 | 2019-08-06 | AML 19 TRIAL | 02 | N | AML MYECHILD 01 IT CYT | 100282861 |
| 240002163 | 240002163 | 1.56 | 62.1 | Curative (C) | null | 2018-12-23 | CHOP R | 02 | N | HYDROXYCARBAMIDE | 100898352 |
| 240002169 | 240002169 | null | null | null | null | 2018-05-12 | Hydroxycarbamide | null | null | CNS LGG 2004 03 VINC WEEKLY+ CARBO | 100945623 |
| 240002172 | 240002172 | null | null | null | null | 2018-09-29 | null | null | null | AML19 TRIAL | 101672433 |
| 240002174 | 240002174 | 1.57 | 80 | Curative (C) | 2019-12-03 | 2019-12-04 | null | 02 | N | TRIPLE INTRATHECAL | 100903268 |
| 240002176 | 240002176 | null | null | null | null | 2016-09-11 | AML 19 TRIAL | null | null | HYDROXYCARBAMIDE | 101246083 |
| 240002177 | 240002177 | 1.68 | 105 | 03 | null | 2018-03-24 | BENDAMUSTINE + RITUXIMAB | 02 | N | CHOP | 100824768 |
| 240002182 | 240002182 | 1.54 | 99.8 | null | null | 2018-06-19 | ALL Interim Guide 2019 Induction B | 02 | N | BENDAMUSTINE + RITUXIMAB | 100815488 |
| 240002183 | 240002183 | 1.82 | 61.1 | 03 | null | 2019-10-09 | null | N | N | AML19 TRIAL | 100950155 |
| 240002186 | 240002186 | null | null | null | null | 2020-08-29 | null | null | null | AML MYECHILD 01 IT CYT | 101485933 |
| 240002188 | 240002188 | null | null | null | null | 2018-12-17 | null | null | null | METHOTREXATE | 100775225 |
| 240002189 | 240002189 | null | null | null | null | 2019-10-26 | AML 18 TRIAL | null | null | AML18 TRIAL | 100197632 |
| 240002192 | 240002192 | 1.87 | 88.55 | Palliative (P) | null | 2019-07-31 | null | 02 | N | DA | 100219294 |
| 240002197 | 240002197 | 1.7 | 63.8 | Curative (C) | 2018-10-26 | 2018-10-26 | null | 02 | null | RITUXIMAB | 101344732 |
| 240002200 | 240002200 | null | null | null | null | 2017-07-07 | GEMTUZUMAB OZOGAMICIN | null | null | CYTARABINE | 100841784 |
| 240002201 | 240002201 | null | null | null | null | 2018-12-21 | null | null | null | IBRUTINIB | 101430526 |
| 240002203 | 240002203 | null | null | null | null | 2019-03-28 | Hydroxycarbamide | null | null | NOT MATCHED | 100314970 |
| 240002204 | 240002204 | 1.73 | 77.6 | Curative (C) | 2017-07-03 | 2017-07-03 | AML16 DA 3+10 | 02 | N | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 101625150 |
| 240002214 | 240002214 | 1.71 | null | Curative (C) | null | 2018-11-29 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101814457 |
| 240002241 | 240002241 | 1.64 | 92.4 | Curative (C) | null | 2018-10-05 | CYTARABINE + DAUNORUBICIN | 02 | N | HYDROXYCARBAMIDE | 100540022 |
| 240002249 | 240002249 | 1.85 | 80.4 | Curative (C) | null | 2020-08-21 | null | 01 | Y | HYDROXYCARBAMIDE | 101088871 |
| 240002251 | 240002251 | null | null | null | null | 2017-04-10 | Azacitidine | null | null | NOT MATCHED | 100816566 |
| 240002255 | 240002255 | 0 | 0 | 03 | 2019-05-23 | 2019-05-24 | CYTARABINE + DAUNORUBICIN | N | N | AML19 TRIAL | 100543161 |
| 240002271 | 240002271 | null | null | null | null | 2018-09-26 | null | null | null | AML18 TRIAL | 100219805 |
| 240002274 | 240002274 | 1.79 | 75 | Adjuvant (A) | null | 2018-04-11 | AML 19 TRIAL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101710290 |
| 240002275 | 240002275 | 1.63 | 57.6 | Curative (C) | null | 2016-09-12 | null | 02 | N | DA | 100438684 |
| 240002284 | 240002284 | 1.78 | 61.7 | Curative (C) | null | 2016-06-29 | AML 19 TRIAL | null | N | DA | 101789408 |
| 240002287 | 240002287 | 1.65 | 77.5 | Curative (C) | null | 2016-10-24 | null | 2 | N | DA | 101567333 |
| 240002293 | 240002293 | 1.85 | 0 | 03 | null | 2017-08-31 | AML16 DA 3+10 | N | N | TOPOTECAN | 100321696 |
| 240002294 | 240002294 | 1.72 | 49.3 | 03 | null | 2016-05-04 | null | 02 | Y | CYTARABINE + DAUNORUBICIN | 100792389 |
| 240002299 | 240002299 | 1.62 | 85.2 | Adjuvant (A) | null | 2018-08-22 | CHOP R - 21 days | N | N | CYTARABINE + DAUNORUBICIN | 101851129 |
| 240002301 | 240002301 | null | 78.3 | Curative (C) | null | 2019-02-20 | FCR Oral - Cycle 1 | 02 | N | HYDROXYCARBAMIDE | 100615797 |